在急性失补性心力衰竭中最佳初始静脉循环利尿剂量
Joshua A Jacobs1,2, Spencer J Carter3, Griffin Bullock3
1Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
JACC. Advances
|September 18, 2024
概括
在急性不补偿性心力衰竭 (ADHF) 患者中,较高的家庭利尿剂剂量显著降低了获得最佳初始静脉注射 (IV) 利尿剂剂量的机会. 这影响了再入院的风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 近一半的急性不补偿性心力衰竭 (ADHF) 患者在未解决的拥堵的情况下出院,增加了再住院的风险.
- 低于最佳的静脉注射 (IV) 循环利尿剂剂量可能会导致持续的堵塞.
- 家庭口服利尿剂剂量可能会影响最初的IV利尿剂剂量策略.
研究的目的:
- 在ADHF患者中研究家庭口服循环利尿剂量与最佳初始IV循环利尿剂量之间的关联.
- 为了确定最佳的初始IV循环利尿剂剂量是否会影响住院时间和30天再入院率.
主要方法:
- 对3269名在家用口服循环利尿剂 (2014-2021) 的成年ADHF患者进行了回顾性分析.
- 根据家庭剂量分类的患者:低 (≤40毫克),中等 (>40-80毫克) 和高 (>80毫克) 的洛塞米德等效剂.
- 最佳初始IV剂量定义为≥2倍的家庭口服剂量;Poisson回归用于分析关联.
主要成果:
- 在67.9%的患者中,获得了最佳的初始静脉注射剂量.
- 最佳IV剂量的患病率在低家庭剂量中最高 (95.5%),在中等 (59.9%) 和高 (4.0%) 家庭剂量中显著下降.
- 较高的家庭利尿剂剂量与获得最佳初始静脉注射剂量的可能性较低密切相关 (高:aPR 0.05;中:aPR 0.66).
- 在最佳和亚最佳IV剂量组之间没有观察到停留时间或30天再入院的显著差异.
结论:
- 家庭循环利尿剂量是影响ADHF最佳初始IV利尿治疗的关键因素.
- 目前的剂量策略可能无法充分考虑家庭利尿剂的使用,这可能导致不理想的治疗.
- 需要进行进一步的研究,以优化ADHF患者的IV利尿剂方案,以其家庭口服利尿剂方案为基础.
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
8.8K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.3K
相关概念视频
01:22Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
01:26Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
473
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
473
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396